Search Results

You are looking at 51 - 60 of 133 items for :

  • "chronic hepatitis C" x
  • Refine by Access: All Content x
Clear All
Orvosi Hetilap
Authors: Béla Hunyady, Judit Gervain, Gábor Horváth, Mihály Makara, Alajos Pár, Ferenc Szalay, László Telegdy, and István Tornai

–1155. [Hungarian] Zeuzem, S., Feinman, S. V., Rasenack, J., et al.: Peginterferon alfa-2a in patients with chronic hepatitis C. N. Engl. J. Med., 2000, 343, 1666–1672. Fried, M. W

Open access

Ascione, A., de Luca, M., Tartaglione, M. T. és mtsai: Peginterferon alpha-2a plus ribavirin versus peginterferon alpha-2b plus ribavirin in naïve patients with chronic hepatitis C virus infection: results of a prospective randomised trial. J. Hepatol

Restricted access

versus peginterfeon alpha-2b plus ribavirin in naive patients with chronic hepatitis C virus infection: results of a prospective randomised trial. J. Hepatol., 2008, 48 , S370. Tartaglione M. T

Restricted access
Orvosi Hetilap
Authors: Gabriella Pár, Andrea Trosits, Ferenc Pakodi, Imre Szabó, József Czimmer, Anita Illés, Szilárd Gódi, Judit Bajor, Patrícia Sarlós, Péter Kenyeres, Attila Miseta, Áron Vincze, and Alajos Pár

Castéra, L., Vergniol, J., Foucher, J., et al.: Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology, 2005, 128 (2) , 343

Restricted access

1233 Horváth, G., Tolvaj, Gy., Halász, T., Stotz, Gy.: The Role and the Possibilities of Natural Interferon Treatment for Chronic Hepatitis C: Our Experiences with Natural

Restricted access

hepatitis C patológiája.] Orv Hetil. 2015; 156: 836–839. [Hungarian] 4 Horváth G, Halász T, Makara M, et al. New era in the treatment of chronic hepatitis C – novel direct acting

Restricted access

hepatitis viruses. Immunity, 2014, 40 (1), 13–24. 6 Thimme, R.: Immunity and inflammation in chronic hepatitis C – Does treatment help? The American Association of the

Restricted access

Usluer, G., Erben, N., Aykin, N., et al.: Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis. C. Eur. J. Clin. Microbiol. Infect. Dis., 2012, 31 (8), 1873

Open access

plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 2001, 358 , 958–965. Gordon S. C. Peginterferon alpha-2b plus ribavirin compared with

Restricted access
Orvosi Hetilap
Authors: Evelin Berta, Anna Egresi, Anna Bacsárdi, Zsófia Gáspár, Gabriella Lengyel, and Krisztina Hagymási

. Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside. Semin Immunopathol. 2013; 35: 111–120. 5 Szalay F. Primary liver cancer and hepatitis C infection. In

Open access